are glp 1 drugs expensive Comparing Ozempic, Wegovy and Other GLP-1 GLP-1 Antagonists Increase Plan Drug

R&D and Innovation: Pharmaceutical companies are continuing to invest in the development and innovation of GLP-1RA drugs that should lead to increased efficacy, further use cases and reduced side effects

(accessed August 2020)

[22,25] GLP-1 receptor agonists are currently classified as Food and Drug Administration (FDA) pregnancy category C, indicating that while animal studies have shown adverse fetal effects, adequate and well-controlled studies in pregnant women are deficient, and these agents are not recommended for use during pregnancy

For sustainable weight loss and appetite regulation, the modest GLP-1 bump from allulose is unlikely to replace medical-grade therapy